NASDAQ:ARTC - ArthroCare Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare's two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It's Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company. Receive ARTC News and Ratings via Email Sign-up to receive the latest news and ratings for ARTC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Equipment SectorN/A SymbolNASDAQ:ARTC CUSIP04313610 Webwww.arthrocare.com Phone+1-512-3913900 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 ArthroCare (NASDAQ:ARTC) Frequently Asked Questions What is ArthroCare's stock symbol? ArthroCare trades on the NASDAQ under the ticker symbol "ARTC." What is the consensus analysts' recommendation for ArthroCare? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ArthroCare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." Who are ArthroCare's key executives? ArthroCare's management team includes the folowing people: Gayle Wiley, Chief Human Resource Officer, Senior Vice PresidentJean A. Woloszko M.D., Ph.D., Senior Vice President - Research and Development, Chief Technology Officer (Age 56)Richard W. Rew II, Senior Vice President, General Counsel, Secretary (Age 49)Scott Schaffner, Senior Vice President, General Manager - Sports Medicine (Age 44)Fred B. Dinger III, Senior Vice President, General Manager of ENTJames L. Pacek, Senior Vice President - Global Markets and Sales Operations (Age 65)Bruce C. Prothro, Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance (Age 52)Fabiana Lacerca-Allen, Independent Director (Age 47) Has ArthroCare been receiving favorable news coverage? Headlines about ARTC stock have been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. ArthroCare earned a media sentiment score of 0.06 on Accern's scale. They also assigned news coverage about the medical device company an impact score of 46.78 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. How do I buy shares of ArthroCare? Shares of ARTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How can I contact ArthroCare? ArthroCare's mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company can be reached via phone at +1-512-3913900. MarketBeat Community Rating for ArthroCare (NASDAQ ARTC)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 108 (Vote Outperform)Underperform Votes: 95 (Vote Underperform)Total Votes: 203MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote "Outperform" if you believe ARTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARTC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: How do investors use RSI to grade stocks?